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Most rodents are small and short-lived, but several lineages have independently evolved
long lifespans without a concomitant increase in body-mass. Most notable are the two
subterranean species naked mole rat (NMR) and blind mole rat (BMR) which have
maximum lifespans of 32 and 21 years, respectively. The longevity of these species has
sparked interest in the tumor suppression strategies that may have also evolved, because
for many rodent species (including mice, rats, guinea pigs, gerbils, and hamsters) tumors
are a major source of late-life mortality. Here, we review the recent literature on anti-cancer
mechanisms in long-lived rodents. Both NMR and BMR seem to have developed tumor
defenses that rely on extra-cellular signals. However, while the NMR relies on a form of
contact inhibition to suppress growth, the BMR evolved a mechanism mediated by the
release of interferon, and rapid necrotic cell death. Although both organisms ultimately
rely on canonical downstream tumor suppressors (pRB and p53) the studies reveal species
can evolve different strategies to achieve tumor-resistance. Importantly, studies of these
cancer-resistant rodents may benefit human health if such mechanisms can be activated
in human cells.
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Mice have become the preferred model for cancer research due
to the presence of a powerful arsenal of molecular and genetic
tools, their short generation time, strain variety, and propensity
for neoplasia. A major goal of cancer research is to understand
the genetic and molecular changes that underlie transformation
and what defense mechanisms fail as people grow older or are
exposed to oncogenic insults. Due to the extreme tumor propen-
sity of mice, focusing research solely in this species maymiss some
important tumor suppression mechanisms used by longer-lived
animals.
Some important differences at the molecular level between
mouse and human cells have already been identified. The tumor
suppression profile of mice is markedly different from that of
human cells, with the most immediate distinction being the pres-
ence of telomerase activity in somatic tissue (Gorbunova and
Seluanov, 2009). Mouse fibroblasts require fewer mutations to
transform than human cells; elimination of pRB and p53 signal-
ing coupled with constitutive Ras signaling is sufficient for mice
whereas humans require the activation of telomerase as well as
mutations that prevent dampening of the AKT signaling pathway
(such as PP2A or PTEN) (Hahn and Weinberg, 2002; Rangarajan
and Weinberg, 2003). The three products of the INK4 tumor
suppression locus, p15INK4b, p16INK4a, and ARF, contribute dif-
ferently to the tumor-resistance of human and mice, with ARF
loss being muchmore deleterious to mice than humans (Kim and
Sharpless, 2006).
To find novel tumor suppressive mechanisms that could
potentially be applied to human treatments, we chose to study
organisms that have a tumor-resistance profile similar to that of
humans, but are tractable to research and investigation in ways
similar to mice. Furthermore, by investigating animals that are
phylogenetically related to Murinae, we could ask questions about
the evolution of tumor suppression mechanisms (and longevity
in general). New results from non-model rodents show that there
are still gaps in our understanding of anti-cancer mechanisms.
Currently, we are investigating two such non-standard model
rodent species: the naked mole rat (Heterocephalus glaber, here-
after referred to as “NMR”) and the blind mole rat (Spalax sp. or
Nannospalax sp., hereafter referred to as “BMR”) (Figure 1).
H. glaber has been of interest to a wide range of biologists due
to its unusual life history traits and adaptations for a subterranean
ecological niche. It is considered to be a eusocial rodent, with
only one breeding female per colony (and is consequently a natu-
rally highly inbred animal), and has a maximum lifespan of more
than 30 years (Buffenstein and Jarvis, 2002; Buffenstein, 2005,
2008) making it an outlier on the body-mass/longevity plot at the
same order as H. sapiens. Furthermore, it has a much lower inci-
dence of neoplasia than traditional inbred laboratory mice, with
no observed tumors from various laboratories housing thousands
of the rodents (Edrey et al., 2011).
The NMR has already started yielding interesting observa-
tions regarding its tumor-resistance, despite being a relatively
new experimental animal. In a 2009 paper by Seluanov et al.,
we showed that NMR fibroblasts grow much more slowly in tis-
sue culture than other rodent cells, and halt their cell cycle at
much lower cell densities than other rodents (a phenomenon
termed early contact inhibition, or ECI) (Seluanov et al., 2009).
NMRs were also shown to be highly resistant to induced tumori-
genesis: primary fibroblasts could not be transformed (induced
into anchorage independent growth) solely by disrupting p53 and
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FIGURE 1 | Images of naked mole rat (right) and blind mole rat (left).
pRB in the presence of oncogenic Ras signaling, the cells had to
undergo additional mutations during passaging in tissue culture
to allow transformation. The nature of the mutations was not
established, but disruption of p16INK4a was observed, as well as
a loss of the ECI phenotype. Therefore, although loss of ECI in
tissue culture was not sufficient for transformation, it was a nec-
essary step before the cells could undergo anchorage independent
growth in soft agar.
The tumor-resistance of NMR cells has also been investigated
in vivo by Liang et al. by injection of NMR cells with various
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FIGURE 2 | Rodent phylogeny. The positions of naked mole rat, blind mole rat, and mouse are indicated. The tree topology is based on molecular phylogenies
inferred from Meredith et al. (2011).
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combinations of transforming factors into immunocompromised
mice (Liang et al., 2010). Again, knockout of the p53 and pRB
pathways by LargeT antigen was not sufficient to induce tumori-
genesis, even in the presence of a constitutive Ras oncogenic
protein, while these mutations were sufficient to allowmouse cells
to form large tumor masses in the immunocompromised mice.
Tumor formation was observed, however, by addition of hTERT
in addition to these other factors. While NMR fibroblasts express
their own telomerase (Seluanov et al., 2007; Gomes et al., 2011)
and can be passaged indefinitely in tissue culture, the additional
pro-growth targets of hTERT (Rahman et al., 2005; Lee et al.,
2008) may be sufficient to induce tumor formation when present
with other transforming factors.
The BMR shows a similar longevity and tumor-resistance
(de Magalhaes and Costa, 2009; Nasser et al., 2009) to the
NMR despite being phylogenetically more related to mice. They
are also long-lived and subterranean, although they are solitary
and genetically heterogeneous. In our recent study Gorbunova
et al. showed that in tissue culture, BMR fibroblasts displayed a
novel phenotype which we named concerted cell death (CCD)
(Gorbunova et al., 2012). Here, fibroblasts grow normally for sev-
eral population doublings before undergoing synchronized rapid
cell death. Like the NMR, the BMR also has somatic telomerase
expression, which eliminated a telomere attrition-based response
as the culprit. We showed that in both growing and dying cells,
the telomeres were still long and telomerase was still active.
Because the death of cells was synchronized, we hypothesized
that during growth, a signaling factor was being secreted that
would kill cells upon reaching a threshold concentration. The
authors identified interferon beta (IFN-β) as the secreted factor
that was increasingly released by the cells into the media dur-
ing passage in tissue culture. Freshly isolated primary BMR cells
treated with media conditioned by BMR cells that were near CCD
were rapidly induced to undergo CCD themselves. It was also
possible to induce very high levels of apoptosis in mouse lines
(but not human lines, possibly due to divergence in the struc-
ture of the IFN-β receptor). We interpreted the secretion of IFN-β
as a response to rapid growth in tissue culture, reflecting the
sensitivity of the cells to over-proliferation or abnormalities in
the local microenvironment. Intriguingly, the BMR evolved this
p53-dependent mechanism despite undergoing a mutation in its
p53 gene as an adaptation to hypoxia that renders it less capa-
ble of directly promoting apoptosis (Ashur-Fabian et al., 2004).
Presumably, the other targets of p53 are sufficient to kill the cell
in the presence of IFN-β.
The BMR CCD and the NMR ECI responses are markedly
different in their phenotype (cell death vs. growth arrest) and
show how convergent evolution toward tumor-resistance can take
different paths. Nonetheless, there are some important similar-
ities. In both cases, the authors show that elimination of both
the pRB and the p53 pathways is important. If either tumor sup-
pression pathway is left intact, the cells will still undergo arrest
or death. This is one trait which these long-lived rodents share
more with humans than mice. Additionally, in both NMR and
BMR an extra-cellular signal is mediating some aspect of the
tumor-resistance (cell density and interferon response, respec-
tively), suggesting that in long-lived species with somatic telom-
erase activity, selection favors increased cellular sensitivity to the
external environment.
During the evolution of extreme longevity in rodents, selec-
tion for tumor-resistance seems to be tremendously important
(Figure 2). Comparative studies in rodents are yielding novel
insights into the evolution of tumor suppressor mechanisms,
which seem to arise sporadically rather than being a conserved
basal trait of the rodent lineage. Interestingly, each lineage evolves
its own tumor suppression mechanism, which means there may
more to learn from other small, long-lived rodents, such as the
Eastern gray squirrel, chinchilla, or muskrat. By learning about
alternative tumor suppression mechanisms evolving in different
lineages, novel targets for anti-cancer therapy may be revealed or
important cell cycle regulatory circuits hitherto ignored may be
discovered.
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